We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.75%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3B
AUM Growth
-$129M
(-4.1%)
Cap. Flow
-$405M
Cap. Flow
% of AUM
-13.51%
Top 10 Holdings %
Top 10 Hldgs %
30.38%
Holding
104
New
28
Increased
19
Reduced
31
Closed
14
Top Buys
| 1 |
iRhythm Holdings
IRTC
|
+$56.7M |
| 2 |
Guardant Health
GH
|
+$50.2M |
| 3 |
GENB
Generate Biomedicines
GENB
|
+$43.9M |
| 4 |
Monte Rosa Therapeutics
GLUE
|
+$43.2M |
| 5 |
argenx
ARGX
|
+$42.2M |
Top Sells
| 1 |
Edgewise Therapeutics
EWTX
|
+$82.6M |
| 2 |
Align Technology
ALGN
|
+$59.5M |
| 3 |
CG Oncology
CGON
|
+$50.2M |
| 4 |
RAPT
RAPT Therapeutics
RAPT
|
+$31.5M |
| 5 |
Legend Biotech
LEGN
|
+$28.2M |
Sector Composition
| 1 | Healthcare | 87.27% |
| 2 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRUG
26
Bright Minds Biosciences
DRUG
$745M
| $39.4M | 1.31% |
539,708
+215,350
| +66% | +$17.3M |
|
27
CareDx
CDNA
$1.54B
| $37.7M | 1.26% |
2,173,146
+587,926
| +37% | +$11.1M |
|
28
Intuitive Surgical
ISRG
$138B
| $35.6M | 1.19% |
77,297
-6,120
| -7% | -$3.1M |
|
29
Inspire Medical Systems
INSP
$1.46B
| $34.9M | 1.17% |
677,570
+136,680
| +25% | +$9.57M |
|
30
Penumbra
PEN
$12.5B
| $34.6M | 1.15% |
105,352
-4,800
| -4% | -$1.63M |
|
31
Transmedics
TMDX
$2.61B
| $32.7M | 1.09% |
329,391
+14,050
| +4% | +$1.83M |
|
|
SLNO
32
DELISTED
Soleno Therapeutics
SLNO
| $32.1M | 1.07% |
959,259
-228,600
| -19% | -$8.96M |
|
33
Dyne Therapeutics
DYN
$3.97B
| $30.5M | 1.02% |
1,681,998
+203,669
| +14% | +$3.51M |
|
34
Maravai LifeSciences
MRVI
$1.04B
| $29M | 0.97% |
10,240,164
+1,886,877
| +23% | +$6.4M |
|
35
Illumina
ILMN
$28.3B
| $28.3M | 0.94% |
229,215
-40,458
| -15% | -$5.31M |
|
36
Kymera Therapeutics
KYMR
$9.39B
| $28.1M | 0.94% |
337,559
-116,700
| -26% | -$9.24M |
|
37
BioMarin Pharmaceuticals
BMRN
$11.4B
| $28.1M | 0.94% |
497,020
-104,500
| -17% | -$6.09M |
|
38
Nurix Therapeutics
NRIX
$2.48B
| $27.1M | 0.91% |
1,750,766
-433,098
| -20% | -$7.18M |
|
39
Rhythm Pharmaceuticals
RYTM
$7.52B
| $27M | 0.9% |
+310,628
| New | +$30.2M |
|
40
Danaher
DHR
$142B
| $26.4M | 0.88% |
139,327
+21,100
| +18% | +$4.49M |
|
41
Establishment Labs
ESTA
$2.67B
| $26.3M | 0.88% |
+463,600
| New | +$31.7M |
|
|
TECX
42
Tectonic Therapeutic
TECX
$613M
| $26.2M | 0.87% |
847,151
-80,373
| -9% | -$1.98M |
|
43
Natera
NTRA
$39.7B
| $25.8M | 0.86% |
129,000
+17,500
| +16% | +$3.77M |
|
44
Corvus Pharmaceuticals
CRVS
$1.25B
| $25.6M | 0.86% |
+1,752,798
| New | +$28M |
|
45
Fulcrum Therapeutics
FULC
$237M
| $24M | 0.8% |
3,134,922
+73,700
| +2% | +$684K |
|
46
Zura Bio
ZURA
$512M
| $23.7M | 0.79% |
3,988,989
+808,600
| +25% | +$4.88M |
|
47
Alphatec Holdings
ATEC
$1.39B
| $23.6M | 0.79% |
+2,172,725
| New | +$31.6M |
|
|
DMRA
48
Damora Therapeutics
DMRA
$1.91B
| $23.2M | 0.77% |
+894,846
| New | +$23M |
|
49
Boston Scientific
BSX
$64B
| $21.7M | 0.73% |
+346,467
| New | +$27.7M |
|
50
Vera Therapeutics
VERA
$3.05B
| $21.1M | 0.7% |
523,824
-260,918
| -33% | -$11.2M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM